{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:48:25Z","timestamp":1771490905957,"version":"3.50.1"},"reference-count":24,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/ol.2014.2739","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T13:03:58Z","timestamp":1416920638000},"page":"881-886","source":"Crossref","is-referenced-by-count":7,"title":["Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid"],"prefix":"10.3892","volume":"9","author":[{"given":"WEIHUA","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIA","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENGYAN","family":"PEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGYU","family":"JI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WANSHAN","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUNSHAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUOSHENG","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"key20180108103142_b1-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(02)01080-2","article-title":"Cellular memory and the histone code","volume":"111","author":"Turner","year":"2002","journal-title":"Cell"},{"key":"key20180108103142_b2-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10585-007-9131-5","article-title":"Histone deacetylases: target enzymes for cancer therapy","volume":"25","author":"Mottet","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"key20180108103142_b3-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(08)70004-4","article-title":"Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis","volume":"9","author":"Weichert","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20180108103142_b4-ol-09-02-0881","first-page":"194","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nature"},{"key":"key20180108103142_b5-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2174\/1381612053507567","article-title":"A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors","volume":"11","author":"Mork","year":"2005","journal-title":"Curr Pharm Des"},{"key":"key20180108103142_b6-ol-09-02-0881","first-page":"337","article-title":"HDAC inhibitors: a potential new category of anti-tumor agents","volume":"4","author":"Pan","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"key20180108103142_b7-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"key20180108103142_b8-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors","volume":"45","author":"Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"key20180108103142_b9-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v8.i1.74","article-title":"High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma","volume":"8","author":"Chen","year":"2002","journal-title":"World J Gastroenterol"},{"key":"key20180108103142_b10-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/174580a0","article-title":"Abnormal properties of histones from malignant cells","volume":"174","author":"Cruft","year":"1954","journal-title":"Nature"},{"key":"key20180108103142_b11-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"key":"key20180108103142_b12-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nature03672","article-title":"Global histone modification patterns predict risk of prostate cancer recurrence","volume":"435","author":"Seligson","year":"2005","journal-title":"Nature"},{"key":"key20180108103142_b13-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.leukres.2004.11.022","article-title":"Antileukemia activity of the combination of 5-aza-2\u2032-deoxycytidine with valproic acid","volume":"29","author":"Yang","year":"2005","journal-title":"Leuk Res"},{"key":"key20180108103142_b14-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3748\/wjg.v9.i11.2450","article-title":"Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance","volume":"9","author":"Zhou","year":"2003","journal-title":"World J Gastroenterol"},{"key":"key20180108103142_b15-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","article-title":"Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells","volume":"90","author":"Catalano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108103142_b16-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1381612003400948","article-title":"Cell cycle molecular targets in novel anticancer drug discovery","volume":"6","author":"Buolamwini","year":"2000","journal-title":"Curr Pharm Des"},{"key":"key20180108103142_b17-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nature04985","article-title":"Mechanism limiting centrosome duplication to once per cell cycle","volume":"442","author":"Tsou","year":"2006","journal-title":"Nature"},{"key":"key20180108103142_b18-ol-09-02-0881","first-page":"262","article-title":"Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells","volume":"60","author":"Shin","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108103142_b19-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1349-7006.2006.00195.x","article-title":"Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53\/p21WAF1\/CIP1 pathway","volume":"97","author":"Park","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180108103142_b20-ol-09-02-0881","first-page":"863","article-title":"Activation of p53\/p21Waf1\/Cip1 pathway by 5-aza-2\u2032-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells","volume":"26","author":"Pulukuri","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180108103142_b21-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","article-title":"Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo","volume":"12","author":"Luong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108103142_b22-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BST0360001","article-title":"Caspase activation cascades in apoptosis","volume":"36","author":"Logue","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"key20180108103142_b23-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/onc.2008.297","article-title":"Caspases in apoptosis and beyond","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"key20180108103142_b24-ol-09-02-0881","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.2739\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T13:29:49Z","timestamp":1515418189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.2739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,25]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/ol.2014.2739"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.2739","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]}}}